Efficacy and Safety of Transarterial Chemoembolization Plus Lenvatinib with or Without Tislelizumab as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Jiang J, Zhang H, Lai J, Zhang S, Ou Y, Fu Y, Zhang L

Journal of Hepatocellular Carcinoma 2024, 11:1607-1622

Published Date: 24 August 2024